Please assess the completion status of the following clinical trial:

Trial Title: Study of Using the Hyper-CL™ Lens (Hyper Osmotic Contact Lens) in Subjects Suffering From Corneal Edema

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject is over 18 years old~2. Subject with corneal edema in the visual access~3. Subject with visual acuity of 6/20 or worse (equivalent ETDRS) clinically explained by corneal edema~4. Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study-specific tests or procedures are performed.~Exclusion Criteria:~1. Subject with active Herpes keratitis~2. Subject with scarred cornea~3. Subject who is suffering from erosions and/or infections of the cornea (red eye)~4. Subject with glaucoma shunts (e.g. Ahmed valve) and or bleb~5. Subject who require chronic administration of any topical ophthalmic beside lubrication eye drops and steroids or anti glaucoma drags~6. Subject who is currently participating or have participated in an investigational study, other than this study, within the past 60 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Treatment A-B (Type: EXPERIMENTAL): Treatment A: Hyper-CL™ lens + salt solution + antibiotics drops (7 days) Treatment B: Regular soft contact lens +salt solution+ antibiotics drops (7 days) One week (7 days) of washout without any treatment will be between treatments.
- Treatment B-A (Type: EXPERIMENTAL): Treatment A: Hyper-CL™ lens + salt solution + antibiotics drops (7 days) Treatment B: Regular soft contact lens +salt solution+ antibiotics drops (7 days) One week (7 days) of washout without any treatment will be between treatments.

Based on this trial design, predict the completion outcome and termination type (if applicable).